article

Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphoma

Myron S Czuczman, Stephen Kahanic, Andres Forero, Glen Davis, Mihaela Munteanu and 5 more (2015) ANNALS OF HEMATOLOGY

Reference details